Literature DB >> 25617367

Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.

Tanya Dimova1, Margreet Brouwer1, Françoise Gosselin2, Joël Tassignon3, Oberdan Leo1, Catherine Donner2, Arnaud Marchant1, David Vermijlen4.   

Abstract

γδ T cells are unconventional T cells recognizing antigens via their γδ T-cell receptor (TCR) in a way that is fundamentally different from conventional αβ T cells. γδ T cells usually are divided into subsets according the type of Vγ and/or Vδ chain they express in their TCR. T cells expressing the TCR containing the γ-chain variable region 9 and the δ-chain variable region 2 (Vγ9Vδ2 T cells) are the predominant γδ T-cell subset in human adult peripheral blood. The current thought is that this predominance is the result of the postnatal expansion of cells expressing particular complementary-determining region 3 (CDR3) in response to encounters with microbes, especially those generating phosphoantigens derived from the 2-C-methyl-d-erythritol 4-phosphate pathway of isoprenoid synthesis. However, here we show that, rather than requiring postnatal microbial exposure, Vγ9Vδ2 T cells are the predominant blood subset in the second-trimester fetus, whereas Vδ1(+) and Vδ3(+) γδ T cells are present only at low frequencies at this gestational time. Fetal blood Vγ9Vδ2 T cells are phosphoantigen responsive and display very limited diversity in the CDR3 of the Vγ9 chain gene, where a germline-encoded sequence accounts for >50% of all sequences, in association with a prototypic CDR3δ2. Furthermore, these fetal blood Vγ9Vδ2 T cells are functionally preprogrammed (e.g., IFN-γ and granzymes-A/K), with properties of rapidly activatable innatelike T cells. Thus, enrichment for phosphoantigen-responsive effector T cells has occurred within the fetus before postnatal microbial exposure. These various characteristics have been linked in the mouse to the action of selecting elements and would establish a much stronger parallel between human and murine γδ T cells than is usually articulated.

Entities:  

Keywords:  Vγ9Vδ2; fetus; gammadelta; human; neonate

Mesh:

Substances:

Year:  2015        PMID: 25617367      PMCID: PMC4330771          DOI: 10.1073/pnas.1412058112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  89 in total

1.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  A long-playing CD about the γδ TCR repertoire.

Authors:  Adrian Hayday; Pierre Vantourout
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  The generation of human gammadelta T cell repertoires during fetal development.

Authors:  L D McVay; S S Jaswal; C Kennedy; A Hayday; S R Carding
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

Review 4.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

Review 5.  Origins of γδ T cell effector subsets: a riddle wrapped in an enigma.

Authors:  Shawn P Fahl; Francis Coffey; David L Wiest
Journal:  J Immunol       Date:  2014-11-01       Impact factor: 5.422

6.  Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment.

Authors:  Anna M Sherwood; Cindy Desmarais; Robert J Livingston; Jessica Andriesen; Maximilian Haussler; Christopher S Carlson; Harlan Robins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

7.  T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells.

Authors:  Zhinan Yin; ChangHung Chen; Susanne J Szabo; Laurie H Glimcher; Anuradha Ray; Joe Craft
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

8.  Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma.

Authors:  Kirk D C Jensen; Xiaoqin Su; Sunny Shin; Luke Li; Sawsan Youssef; Sho Yamasaki; Lawrence Steinman; Takashi Saito; Richard M Locksley; Mark M Davis; Nicole Baumgarth; Yueh-hsiu Chien
Journal:  Immunity       Date:  2008-06-26       Impact factor: 31.745

9.  γδ T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response.

Authors:  Xun Zeng; Yu-Ling Wei; Jun Huang; Evan W Newell; Hongxiang Yu; Brian A Kidd; Michael S Kuhns; Ray W Waters; Mark M Davis; Casey T Weaver; Yueh-hsiu Chien
Journal:  Immunity       Date:  2012-09-06       Impact factor: 31.745

10.  CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus.

Authors:  Xiaoming Zhang; Brian Mozeleski; Sebastien Lemoine; Edith Dériaud; Annick Lim; Dania Zhivaki; Elie Azria; Camille Le Ray; Gwenaelle Roguet; Odile Launay; Anne Vanet; Claude Leclerc; Richard Lo-Man
Journal:  Sci Transl Med       Date:  2014-05-28       Impact factor: 17.956

View more
  90 in total

1.  A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens.

Authors:  Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2018-11-02       Impact factor: 5.858

2.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

Review 3.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

4.  Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection.

Authors:  Carly A Dillen; Bret L Pinsker; Alina I Marusina; Alexander A Merleev; Orly N Farber; Haiyun Liu; Nathan K Archer; Da B Lee; Yu Wang; Roger V Ortines; Steven K Lee; Mark C Marchitto; Shuting S Cai; Alyssa G Ashbaugh; Larissa S May; Steven M Holland; Alexandra F Freeman; Loren G Miller; Michael R Yeaman; Scott I Simon; Joshua D Milner; Emanual Maverakis; Lloyd S Miller
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

Review 5.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

6.  Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Authors:  Gabriele Pizzolato; Hannah Kaminski; Marie Tosolini; Don-Marc Franchini; Fréderic Pont; Fréderic Martins; Carine Valle; Delphine Labourdette; Sarah Cadot; Anne Quillet-Mary; Mary Poupot; Camille Laurent; Loic Ysebaert; Serena Meraviglia; Francesco Dieli; Pierre Merville; Pierre Milpied; Julie Déchanet-Merville; Jean-Jacques Fournié
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

Review 7.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

8.  BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.

Authors:  Mahboob Salim; Timothy J Knowles; Alfie T Baker; Martin S Davey; Mark Jeeves; Pooja Sridhar; John Wilkie; Carrie R Willcox; Hachemi Kadri; Taher E Taher; Pierre Vantourout; Adrian Hayday; Youcef Mehellou; Fiyaz Mohammed; Benjamin E Willcox
Journal:  ACS Chem Biol       Date:  2017-09-14       Impact factor: 5.100

9.  Immune-mediated syndromes following intravenous bisphosphonate therapy.

Authors:  Noa Markovits; Ronen Loebstein; Ilan Bank
Journal:  Inflammopharmacology       Date:  2017-05-31       Impact factor: 4.473

Review 10.  Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.

Authors:  C David Pauza; Cristiana Cairo
Journal:  Cell Immunol       Date:  2015-03-04       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.